We are live on ! Find out more
TCA

Troluce Capital Advisors Portfolio holdings

AUM $971M
1-Year Est. Return 2.27%
This Fund
S&P 500
This Quarter Est. Return
-6.63%
1 Year Est. Return
+2.27%
3 Year Est. Return
+61.09%
5 Year Est. Return
10 Year Est. Return
AUM
$971M
AUM Growth
-$660M
Cap. Flow
-$635M
Cap. Flow %
-65.37%
Top 10 Hldgs %
88.66%
Holding
90
New
21
Increased
3
Reduced
2
Closed
64

Sector Composition

Rank Sector Weight
1 Miscellaneous 72.51%
2 Industrials 14.82%
3 Healthcare 6.49%
4 Communication Services 5.68%
5 Technology 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$81.2B
$300M 30.94%
+1,000,000
New +$281M
SPCX
2
PUT
SpaceX
SPCX
$1.96T
$167M 17.16%
+975,000
New +$166M
ECHO
3
CALL
EchoStar
ECHO
$26.1B
$86.3M 8.89%
+850,000
New +$104M
AMTM
4
Amentum Holdings
AMTM
$4.93B
$73.7M 7.59%
3,565,399
+2,565,399
+257% +$62M
ECHO
5
EchoStar
ECHO
$26.1B
$55.2M 5.68%
543,602
-56,398
-9% -$6.89M
MLYS icon
6
Mineralys Therapeutics
MLYS
$2.44B
$46.6M 4.8%
1,728,753
+1,073,753
+164% +$29.5M
GSAT icon
7
PUT
Globalstar
GSAT
$10.7B
$40.6M 4.19%
+500,000
New +$40.2M
XBI icon
8
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$39.6M 4.07%
+250,000
New +$33.8M
MIR icon
9
Mirion Technologies
MIR
$4.12B
$27.6M 2.84%
1,539,212
+39,212
+3% +$727K
AEIS icon
10
Advanced Energy
AEIS
$11.2B
$24.2M 2.5%
+65,000
New +$22.7M
GSAT icon
11
CALL
Globalstar
GSAT
$10.7B
$19.1M 1.97%
+235,400
New +$18.9M
STOK icon
12
Stoke Therapeutics
STOK
$1.91B
$16.2M 1.67%
496,416
-156,384
-24% -$5.02M
TKR icon
13
CALL
Timken Company
TKR
$8.51B
$14.3M 1.47%
+98,400
New +$11.8M
AMZN icon
14
CALL
Amazon
AMZN
$2.77T
$11.9M 1.23%
+50,000
New +$12.6M
GD icon
15
General Dynamics
GD
$97.3B
$9.65M 0.99%
+27,250
New +$9.33M
NRG icon
16
CALL
NRG Energy
NRG
$24.7B
$8.54M 0.88%
+58,500
New +$8.42M
BBIO icon
17
CALL
BridgeBio Pharma
BBIO
$14.5B
$7.45M 0.77%
+100,000
New +$7M
Q
18
Qnity Electronics Inc
Q
$25.2B
$4.92M 0.51%
+30,100
New +$4.43M
ENTG icon
19
CALL
Entegris
ENTG
$21.1B
$4.42M 0.46%
+24,600
New +$3.55M
HON icon
20
Honeywell
HON
$66.1B
$3.74M 0.39%
+16,700
New +$3.73M
QXO
21
QXO Inc
QXO
$14B
$3.46M 0.36%
+200,000
New +$3.72M
FOXA icon
22
CALL
Fox Class A
FOXA
$27.7B
$3.23M 0.33%
+62,000
New +$3.83M
INIO
23
INNIO N.V.
INIO
$15.6B
$1.48M 0.15%
+37,500
New +$1.34M
MLYS icon
24
CALL
Mineralys Therapeutics
MLYS
$2.44B
$1.35M 0.14%
+50,000
New +$1.37M
WBD icon
25
CALL
Warner Bros
WBD
$70.9B
$141K 0.01%
+5,300
New +$143K

Similar funds

Troluce Capital Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Troluce Capital Advisors held 90 positions worth $971M, down 40% from $1.63B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Troluce Capital Advisors withdrew a net $635M in Q2 2026, closing 64 positions and reducing 2 holdings. Its most notable exit was Atlanta Braves Holdings Series B, an estimated $85.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, up from 42% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Troluce Capital Advisors opened a new position in Advanced Energy worth $24.2M.

  • Troluce Capital Advisors's largest Q2 2026 buy was Advanced Energy: 65,000 shares worth $24.2M.
  • Troluce Capital Advisors added most to Amentum Holdings in Q2 2026, an estimated $62M increase.
  • Troluce Capital Advisors's biggest Q2 2026 reduction was EchoStar, cutting an estimated $6.89M.
  • Troluce Capital Advisors fully exited Atlanta Braves Holdings Series B in Q2 2026, selling an estimated $85.4M.
  • Troluce Capital Advisors's ten largest holdings make up 89% of its $971M portfolio in Q2 2026.
  • Troluce Capital Advisors opened 21 new positions and closed 64 in Q2 2026.
  • Troluce Capital Advisors's portfolio value fell 40% quarter-over-quarter to $971M.

Based on Troluce Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.